These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32167946)

  • 1. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies.
    Andrieu-Soler C; Soler E
    Curr Opin Hematol; 2020 May; 27(3):141-148. PubMed ID: 32167946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX6 Downregulation Induces
    Li J; Lai Y; Luo J; Luo L; Liu R; Liu Z; Zhao W
    Biomed Res Int; 2017; 2017():9496058. PubMed ID: 29333458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.
    Chou YC; Chen RL; Lai ZS; Song JS; Chao YS; Shen CK
    Mol Cell Biol; 2015 Jul; 35(14):2541-53. PubMed ID: 25986606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule therapeutics to treat the β-globinopathies.
    Yu L; Myers G; Engel JD
    Curr Opin Hematol; 2020 May; 27(3):129-140. PubMed ID: 32167945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
    Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
    Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of fetal globin gene expression in adult erythroid cells.
    Ginder GD
    Transl Res; 2015 Jan; 165(1):115-25. PubMed ID: 24880147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
    Cui S; Engel JD
    Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
    Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
    Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
    Khan F; Ali H; Musharraf SG
    Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel γ-globin inducers among all potential erythroid druggable targets.
    Yu L; Myers G; Schneider E; Wang Y; Mathews R; Lim KC; Siemieniak D; Tang V; Ginsburg D; Balbin-Cuesta G; Singh SA; Phuwakanjana P; Jearawiriyapaisarn N; Khoriaty R; Engel JD
    Blood Adv; 2022 Jun; 6(11):3280-3285. PubMed ID: 35240686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Repressor BCL11A in Erythroid Cells.
    Zheng G; Orkin SH
    Adv Exp Med Biol; 2024; 1459():199-215. PubMed ID: 39017845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients.
    Fibach E; Bianchi N; Borgatti M; Zuccato C; Finotti A; Lampronti I; Prus E; Mischiati C; Gambari R
    Eur J Haematol; 2006 Nov; 77(5):437-41. PubMed ID: 16939628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.
    Fathallah H; Taher A; Bazarbachi A; Atweh GF
    Blood Cells Mol Dis; 2009; 43(1):58-62. PubMed ID: 19346141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
    Boosalis MS; Castaneda SA; Trudel M; Mabaera R; White GL; Lowrey CH; Emery DW; Mpollo MS; Shen L; Wargin WA; Bohacek R; Faller DV; Perrine SP
    Blood Cells Mol Dis; 2011 Aug; 47(2):107-16. PubMed ID: 21641240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing.
    Xu J; Peng C; Sankaran VG; Shao Z; Esrick EB; Chong BG; Ippolito GC; Fujiwara Y; Ebert BL; Tucker PW; Orkin SH
    Science; 2011 Nov; 334(6058):993-6. PubMed ID: 21998251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple physical stresses induce γ-globin gene expression and fetal hemoglobin production in erythroid cells.
    Schaeffer EK; West RJ; Conine SJ; Lowrey CH
    Blood Cells Mol Dis; 2014 Apr; 52(4):214-24. PubMed ID: 24314748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.